Literature DB >> 33989894

Immunity to EBV as revealed by immunedeficiencies.

Benjamin Fournier1, Sylvain Latour2.   

Abstract

Epstein-Barr virus infection is the most common viral latent infection in humans and represents one prototypical model to study immunity to viral infections. In that respect, inborn errors of immunity (IEIs) or primary immunodeficiencies (PIDs) predisposing to severe and chronic EBV infections provide peculiar examples to decipher-specific molecular and cellular components involved in the immune control of EBV-infected cells. Herein, we discuss the recent knowledge and concepts arising from these studies, with a particular focus on 'atypical' EBV infections when EBV enters T, NK and smooth muscle cells, instead of the common 'typical' infection of B cells.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33989894     DOI: 10.1016/j.coi.2021.04.003

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  5 in total

1.  Epstein Barr virus-mediated transformation of B cells from XIAP-deficient patients leads to increased expression of the tumor suppressor CADM1.

Authors:  Christine Engelmann; Patrick Schuhmachers; Hana Zdimerova; Sanamjeet Virdi; Mathias Hauri-Hohl; Jana Pachlopnik Schmid; Adam Grundhoff; Rebecca A Marsh; Wendy Wei-Lynn Wong; Christian Münz
Journal:  Cell Death Dis       Date:  2022-10-22       Impact factor: 9.685

2.  Epstein-Barr Virus Genome Deletions in Epstein-Barr Virus-Positive T/NK Cell Lymphoproliferative Diseases.

Authors:  Wiyada Wongwiwat; Benjamin Fournier; Irene Bassano; Amr Bayoumy; Claudio Elgueta Karstegl; Christine Styles; Ray Bridges; Christelle Lenoir; David BoutBoul; Despina Moshous; Bénédicte Neven; Teru Kanda; Rhys G Morgan; Robert E White; Sylvain Latour; Paul J Farrell
Journal:  J Virol       Date:  2022-05-25       Impact factor: 6.549

Review 3.  Epstein-Barr virus and multiple sclerosis.

Authors:  Samantha S Soldan; Paul M Lieberman
Journal:  Nat Rev Microbiol       Date:  2022-08-05       Impact factor: 78.297

Review 4.  Co-Stimulatory Molecules during Immune Control of Epstein Barr Virus Infection.

Authors:  Christian Münz
Journal:  Biomolecules       Date:  2021-12-28

Review 5.  Do Epstein-Barr Virus Mutations and Natural Genome Sequence Variations Contribute to Disease?

Authors:  Paul J Farrell; Robert E White
Journal:  Biomolecules       Date:  2021-12-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.